[Levamisole-induced changes of cellular immunity in patients with staphyloderma and indications for levamisole administration].
D000293:Adolescent; D000328:Adult; D005667:Furunculosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use*; D008875:Middle Aged; D012874:Skin Diseases, Infectious / Q000188:drug therapy* / Q000276:immunology; D012882:Skin Tests; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
D007978:Levamisole
Kharakteristika izmeneniĭ kletochnogo immuniteta, vyzyvaemykh levamizolom, u bol'nykh stafilodermiiami i pokazaniia k ego primeneniiu.